Suivre
Davide Cusumano
Davide Cusumano
PhD, Fondazione Policlinico Universitario A.Gemelli IRCCS
Adresse e-mail validée de policlinicogemelli.it
Titre
Citée par
Citée par
Année
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative …
L Boldrini, D Cusumano, G Chiloiro, C Casà, C Masciocchi, J Lenkowicz, ...
La radiologia medica 124, 145-153, 2019
1292019
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls
L Boldrini, D Cusumano, F Cellini, L Azario, GC Mattiucci, V Valentini
Radiation Oncology 14, 1-6, 2019
1182019
Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer
D Cusumano, N Dinapoli, L Boldrini, G Chiloiro, R Gatta, C Masciocchi, ...
La radiologia medica 123, 286-295, 2018
1112018
A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer
D Cusumano, G Meijer, J Lenkowicz, G Chiloiro, L Boldrini, C Masciocchi, ...
La radiologia medica 126, 421-429, 2021
832021
A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases
D Cusumano, J Lenkowicz, C Votta, L Boldrini, L Placidi, F Catucci, ...
Radiotherapy and Oncology 153, 205-212, 2020
732020
Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives
D Cusumano, L Boldrini, J Dhont, C Fiorino, O Green, G Güngör, N Jornet, ...
Physica medica 85, 175-191, 2021
682021
Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR
D Cusumano, J Dhont, L Boldrini, G Chiloiro, S Teodoli, M Massaccesi, ...
Radiotherapy and Oncology 129 (3), 456-462, 2018
632018
MR-guided radiotherapy in rectal cancer: first clinical experience of an innovative technology
G Chiloiro, L Boldrini, E Meldolesi, A Re, F Cellini, D Cusumano, ...
Clinical and Translational Radiation Oncology 18, 80-86, 2019
562019
On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
L Placidi, A Romano, G Chiloiro, D Cusumano, L Boldrini, F Cellini, ...
Technical innovations & patient support in radiation oncology 15, 15-21, 2020
492020
In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses
M Carrara, C Tenconi, G Rossi, M Borroni, A Cerrotta, S Grisotto, ...
Radiotherapy and Oncology 118 (1), 148-153, 2016
482016
Towards a modular decision support system for radiomics: A case study on rectal cancer
R Gatta, M Vallati, N Dinapoli, C Masciocchi, J Lenkowicz, D Cusumano, ...
Artificial intelligence in medicine 96, 145-153, 2019
452019
Delta radiomics can predict distant metastasis in locally advanced rectal cancer: the challenge to personalize the cure
G Chiloiro, P Rodriguez-Carnero, J Lenkowicz, C Casa, C Masciocchi, ...
Frontiers in Oncology 10, 595012, 2020
432020
External validation of early regression index (ERITCP) as predictor of pathologic complete response in rectal cancer using magnetic resonance-guided radiation therapy
D Cusumano, L Boldrini, P Yadav, G Yu, B Musurunu, G Chiloiro, A Piras, ...
International Journal of Radiation Oncology* Biology* Physics 108 (5), 1347-1356, 2020
412020
Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation
D Cusumano, L Boldrini, P Yadav, G Yu, B Musurunu, G Chiloiro, A Piras, ...
Physica Medica 84, 186-191, 2021
372021
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development
G Chiloiro, D Cusumano, P de Franco, J Lenkowicz, L Boldrini, D Carano, ...
La radiologia medica 127 (1), 11-20, 2022
352022
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy
R Autorino, B Gui, G Panza, L Boldrini, D Cusumano, L Russo, ...
La radiologia medica 127 (5), 498-506, 2022
342022
Delta radiomics analysis for local control prediction in pancreatic cancer patients treated using magnetic resonance guided radiotherapy
D Cusumano, L Boldrini, P Yadav, C Casà, SL Lee, A Romano, A Piras, ...
Diagnostics 11 (1), 72, 2021
332021
On the accuracy of bulk synthetic CT for MR-guided online adaptive radiotherapy
D Cusumano, L Placidi, S Teodoli, L Boldrini, F Greco, S Longo, F Cellini, ...
La radiologia medica 125, 157-164, 2020
282020
Dosimetric verification of stereotactic radiosurgery/stereotactic radiotherapy dose distributions using Gafchromic EBT3
D Cusumano, ML Fumagalli, M Marchetti, L Fariselli, E De Martin
Medical Dosimetry 40 (3), 226-231, 2015
272015
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases
J Lenkowicz, C Votta, M Nardini, F Quaranta, F Catucci, L Boldrini, ...
Radiotherapy and Oncology 176, 31-38, 2022
262022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20